11
2.
"
,
!
I
/"
(
$
"%)
.
"
( *
"%
Ki67
MIB-1
(“DakoCytomation”)
G !
" )
P53
DO-7
(“DakoCytomation”)
G !
& *
: /
CD68
PG-M1
(“DakoCytomation”)
I
) (
/
:"* !* " * !' " ! "
$!
"6
4
6 "%
)
"
2-
* "
"
5
,
" ,6
$
&
*6
- 95
0
, 95
0
, 80
0
–
3
! &
.
"
(
)
$
"
"
, )
(
' *, "
"!
!
"%$
" "*
" 20
".
2
"
! *
$
""
(5
)
6 *
- ) 5
"%,
!' *
)
"
(
*
90-95
0
B
45
. : "
$
! %
!,
6 *
- ) 20-25
.
B "%,
%' * )
& *
)
(
' *
6 "*" "
H
(
$! 3%- !
5
- "
- 20
.
"% '
" ,
!
" - 60
(37
0
B),
"
$!
6 "
- ) – 3
5
.